SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-23-000163
Filing Date
2023-09-26
Accepted
2023-09-26 16:08:55
Documents
1
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1695758927.html 4  
1 FORM 4 wk-form4_1695758927.xml 4 4014
  Complete submission text file 0001824293-23-000163.txt   5617
Mailing Address C/O VALLON PHARAMCEUTICALS, INC. 100 N 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address
Kelly Leanne (Reporting) CIK: 0001398278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 231280559

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations